Health Sector Management Fall Speakers Event — “New Patterns of Innovation: Integrated Models of Biopharma and Diagnostics”
The Health Sector Management Program and The Health Sector Management Alumni Association at Boston University’s School of Management proudly present:
New Patterns of Innovation: Integrated Models of Biopharma and Diagnostics
Tuesday, November 15, 2011; 6-8pm
595 Commonwealth Avenue
Boston, MA 02215
Featuring guest panelists:
Mike Nohaile, Ph.D.Global Head Molecular Diagnostics, Novartis
Matt McManus, MD, Ph.D.President & CEO, PrimeraDx
Moderator, Jeff Elton, Ph.D., CEO, The KEW Group
Event description:
New therapeutic strategies are increasingly the result of insight from pathway biology, genetics, and genomics. This brings together therapeutics and diagnostics in a variety of new ways, supporting new business models, regulatory processes, and reimbursement strategies. While the goal is for patients to be the ultimate beneficiaries of these changes, the interests of pharma/biopharma companies, diagnostics companies, regulators, public reimbursement authorities, and private payers can be at odds. This program brings together considerations of science, strategy, business models, regulation, reimbursement, and clinical practice to explore current trends and future direction in the field.
